Winer EP - Search Results

1

Primary care for survivors of breast cancer.

Burstein HJ, Winer EP. Burstein HJ, et al. Among authors: winer ep. N Engl J Med. 2000 Oct 12;343(15):1086-94. doi: 10.1056/NEJM200010123431506. N Engl J Med. 2000. PMID: 11027744 Review. No abstract available.

2

Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.

Winer EP, Chu L, Spicer DV. Winer EP, et al. Semin Oncol. 1995 Apr;22(2 Suppl 5):72-8; discussion 78-9. Semin Oncol. 1995. PMID: 7740337 Review.

3

Why women gain weight with adjuvant chemotherapy for breast cancer.

Demark-Wahnefried W, Winer EP, Rimer BK. Demark-Wahnefried W, et al. Among authors: winer ep. J Clin Oncol. 1993 Jul;11(7):1418-29. doi: 10.1200/JCO.1993.11.7.1418. J Clin Oncol. 1993. PMID: 8315439 Review.

4

A review of hereditary breast cancer: from screening to risk factor modification.

Warmuth MA, Sutton LM, Winer EP. Warmuth MA, et al. Among authors: winer ep. Am J Med. 1997 Apr;102(4):407-15. doi: 10.1016/s0002-9343(97)00093-4. Am J Med. 1997. PMID: 9217624 Review.

5

Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.

Sutton LM, Warmuth MA, Petros WP, Winer EP. Sutton LM, et al. Among authors: winer ep. Cancer Chemother Pharmacol. 1997;40(4):335-41. doi: 10.1007/s002800050666. Cancer Chemother Pharmacol. 1997. PMID: 9225952 Clinical Trial.

6

Oral 5-FU analogues in the treatment of breast cancer.

Bunnell CA, Winer EP. Bunnell CA, et al. Among authors: winer ep. Oncology (Williston Park). 1998 Oct;12(10 Suppl 7):39-43. Oncology (Williston Park). 1998. PMID: 9830624 Review.

7

Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.

Havlin KA, Ramirez MJ, Legler CM, Harris LN, Matulonis UA, Hohneker JA, Hayes DF, Winer EP. Havlin KA, et al. Among authors: winer ep. Cancer Chemother Pharmacol. 1999;43(1):68-72. doi: 10.1007/s002800050864. Cancer Chemother Pharmacol. 1999. PMID: 9923543 Clinical Trial.

8

Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group.

Goss PE, Winer EP, Tannock IF, Schwartz LH. Goss PE, et al. Among authors: winer ep. J Clin Oncol. 1999 Jan;17(1):52-63. doi: 10.1200/JCO.1999.17.1.52. J Clin Oncol. 1999. PMID: 10458218 Clinical Trial.

9

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

Kantoff PW, Halabi S, Conaway M, Picus J, Kirshner J, Hars V, Trump D, Winer EP, Vogelzang NJ. Kantoff PW, et al. Among authors: winer ep. J Clin Oncol. 1999 Aug;17(8):2506-13. doi: 10.1200/JCO.1999.17.8.2506. J Clin Oncol. 1999. PMID: 10561316 Clinical Trial.

10

Phase I study of Doxil and vinorelbine in metastatic breast cancer.

Burstein HJ, Ramirez MJ, Petros WP, Clarke KD, Warmuth MA, Marcom PK, Matulonis UA, Parker LM, Harris LN, Winer EP. Burstein HJ, et al. Among authors: winer ep. Ann Oncol. 1999 Sep;10(9):1113-6. doi: 10.1023/a:1008323200102. Ann Oncol. 1999. PMID: 10572612 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results